
AC Immune
AC Immune develops precision immunotherapies and diagnostics targeting misfolded proteins for neurodegenerative disease with global pharmaceutical partners.
- Public
AC Immune is a clinical-stage biopharmaceutical company focused on precision medicine for neurodegenerative diseases driven by misfolded proteins, including Alzheimer's, Parkinson's and NeuroOrphan diseases. The company designs and develops proprietary diagnostics and medicines for the diagnosis, treatment and prevention of neurodegenerative diseases using its two clinically validated technology platforms, SupraAntigen and Morphomer.
The company is advancing a clinical-stage pipeline of therapeutic and diagnostic candidates to tackle established and novel disease targets, with a stated strategy to accelerate development of Alzheimer's disease therapeutics, expand into Parkinson's and NeuroOrphan diseases and advance precision medicine-enabling diagnostics. It pursues this work through strategic alliances with leading industry partners such as Takeda, Janssen Pharmaceuticals, Inc. and Eli Lilly and Company.
Similar Companies

Crescendo Biologics

Aprinoia Therapeutics
aprinoia.com

MindImmune Therapeutics
mindimmune.com

Accera
accerapharma.com

ImmuneID

Aztherapies
Neuropore Therapies
neuropore.com

AltPep
altpep.com

Inflammasome Therapeutics
inflam.com

Accro Bioscience
accropeutics.com

AcuraStem
acurastem.com

Neuron23
neuron23.com
Altimmune
altimmune.com

Alzeca Biosciences
alzeca.com
DecImmune Therapeutics
decimmune.com
Quick Facts
Who are AC Immune's competitors?
Companies similar to AC Immune include Crescendo Biologics, Aprinoia Therapeutics, MindImmune Therapeutics and Accera.
When was AC Immune founded?
AC Immune was founded in 2003.
Where is AC Immune's headquarters located?
AC Immune's headquarters is located in Lausanne, CH.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Revenue
- Customer